CRH is trading at $90.14, up 4.15%; available sources do not explain the live-session gain, despite reports of premarket weakness. - Q3 revenue was $11.4 billion, missing forecasts; adjusted EPS of $2.09 beat the cited $2.03 estimate. - CRH cut full-year adjusted EBITDA guidance to $7.8B–$8.0B from $8.1B–$8.5B, citing inflation and subdued residential activity. - The company authorized a buyback of up to $6 billion through 2030.